EchoSolv AS vs LINQ II Insertable Cardiac Monitor
Similar category, different focus. These tools serve overlapping but distinct needs.
Comparability 65/100
Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
AI Verdict
EchoSolv AS is an AI-powered software platform designed to analyze existing echocardiogram measurements for the early identification of severe aortic stenosis risk. In contrast, the LINQ II is an AI-enhanced insertable cardiac monitor that provides long-term, continuous heart rhythm monitoring for diagnosing arrhythmias. While both leverage AI in cardiology for clinical decision support, they address distinct diagnostic challenges and utilize different data sources and technologies.
Choose EchoSolv AS if…
Choose EchoSolv AS if your cardiology department needs to efficiently and accurately identify patients at high risk for severe aortic stenosis from existing echocardiogram measurements. This tool is ideal for providing rapid, AI-powered clinical decision support to prioritize studies for closer review and streamline the diagnostic pathway for sAS, without requiring EMR integration.
View EchoSolv AS →Choose LINQ II Insertable Cardiac Monitor if…
Choose the LINQ II Insertable Cardiac Monitor if your patient requires long-term, continuous heart rhythm monitoring to diagnose infrequent or paroxysmal arrhythmias. This device offers extended monitoring capabilities (up to 4.5 years) with AI-enhanced accuracy and remote management, making it suitable for patients needing prolonged observation outside of a clinical setting.
View LINQ II Insertable Cardiac Monitor →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | EchoSolv AS | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Deployment | Cloud-based | Subcutaneous implant with remote monitoring via mobile app or home communicator. |
| BAA Available | Yes AI-estimated | Unknown |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Yes AI-estimated | Unknown |
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | EchoSolv AS | LINQ II Insertable Cardiac Monitor |
|---|---|---|
| Name | EchoSolv AS | LINQ II Insertable Cardiac Monitor |
| Company | Echo IQ | Medtronic |
| Description | EchoSolv AS is an FDA-cleared, AI-powered clinical decision support platform by Echo IQ that analyzes echocardiograms to identify patients at risk for severe aortic stenosis with high accuracy and efficiency, integrating into existing workflows. | The Medtronic LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring with remote programming and enhanced accuracy for diagnosing arrhythmias. |
| Categories | Cardiology AI, Clinical Decision Support & Reference | Cardiology AI, Clinical Decision Support & Reference |
| Specialties | Cardiology, Cardiothoracic Surgery | Cardiology |
| Key Features | AI-powered clinical decision support for severe aortic stenosis probability, Consistent severe AS probability and guideline check from measurements, Second reader support to help prioritize studies for closer review, Real-world readiness; AI does not use LVOT measurements, Faster clinical review using standardized, measurement-based AI and guideline analysis, Measurement-based AI (analyzes numerical measurements, not images), Designed to fit existing workflows (no EMR integration required, integrates with PACS), Ultra-fast risk detection (under 3 seconds) | AccuRhythm™ AI algorithms for enhanced accuracy, Remote programming capability, Up to 4.5 years of continuous monitoring, MRI compatibility (1.5 and 3.0T), MyCareLink Heart™ mobile app for data transmission, MyCareLink Relay™ home communicator option, Innovative PVC detection algorithm, Pediatric indication (ages 2+) |
Videos
Demos, reviews, and walkthroughs featuring EchoSolv AS and LINQ II Insertable Cardiac Monitor.
Loading videos…
Videos need JavaScript to load. Search YouTube directly →
Frequently Asked Questions
EchoSolv AS is an AI-powered clinical decision support platform that analyzes echocardiograms to identify patients at risk for severe aortic stenosis. LINQ II is an advanced, AI-powered insertable cardiac monitor providing long-term, continuous heart rhythm monitoring for diagnosing arrhythmias.
EchoSolv AS is designed to fit existing workflows, integrating with PACS and not requiring EMR integration. LINQ II utilizes a hybrid deployment model with a MyCareLink Heart mobile app for data transmission and a MyCareLink Relay home communicator option.
EchoSolv AS is a software-based clinical decision support platform that uses measurement-based AI to analyze numerical echocardiogram measurements, not images, for severe aortic stenosis probability. LINQ II is a hardware insertable cardiac monitor that provides continuous heart rhythm monitoring using AccuRhythm AI algorithms for enhanced accuracy in detecting arrhythmias.
EchoSolv AS provides ultra-fast risk detection (under 3 seconds) for severe aortic stenosis based on individual echocardiogram analysis. LINQ II offers long-term, continuous heart rhythm monitoring for up to 4.5 years with its insertable cardiac monitor.